Riccardo Raneri – Pagina 28

Dicembre 15, 2015 Riccardo Raneri

FDA Drug Safety Communication: FDA eliminates the Risk Evaluation and Mitigation Strategy (REMS) for rosiglitazone-containing diabetes medicines

16712/2015
FDA Drug Safety Communication: FDA eliminates the Risk Evaluation and Mitigation Strategy (REMS) for rosiglitazone-containing diabetes medicines

Leggi

Aprile 3, 2016 Riccardo Raneri

FDA – Diabetes medications containing Saxagliptin and Alogliptin: Drug safety communication – Risk of heart failure

05/04/2016
FDA – Diabetes medications containing Saxagliptin and Alogliptin: Drug safety communication – Risk of heart failure

Leggi

Dicembre 15, 2015 Riccardo Raneri

FDA approves Basaglar, the first “follow-on” insulin glargine product to treat diabetes

16/12/2015
FDA approves Basaglar, the first “follow-on” insulin glargine product to treat diabetes

Leggi

Dicembre 29, 2015 Riccardo Raneri

Standards of Medical Care in Diabetes – 2016

Diabetes Care 2016;39:S4-S5 http://care.diabetesjournals.org/content/39/Supplement_1

Leggi

Aprile 3, 2016 Riccardo Raneri

FDA – Drug Safety Communication: FDA revises warnings regarding use of the diabetes medicine metformin in certain patients with reduced kidney function

08/04/2016 http://www.fda.gov/Drugs/DrugSafety/ucm493244.htm?source=govdelivery&utm_medium=email&utm_source=govdelivery

Leggi

Aprile 17, 2016 Riccardo Raneri

EMA – Reviews diabetes medicine canagliflozin – Review follows data on toe amputations in ongoing study

15/04/2016
EMA – Reviews diabetes medicine canagliflozin – Review follows data on toe amputations in ongoing study

Leggi

Gennaio 10, 2016 Riccardo Raneri

FDA approves Integra Omnigraft Dermal Regeneration Matrix to treat diabetic foot ulcers.

January 7, 2016 http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm480564.htm

Leggi

Gennaio 26, 2016 Riccardo Raneri

AIFA – Gestione del diabete in gravidanza: nuovo standard di qualità del NICE

27/01/2016 http://www.agenziafarmaco.gov.it/it/content/gestione-del-diabete-gravidanza-nuovo-standard-di-qualit%C3%A0-del-nice

Leggi

Aprile 17, 2016 Riccardo Raneri

AIFA – Comunicazione EMA su revisione canaglifozin

15/04/2016
AIFA – Comunicazione EMA su revisione canaglifozin

Leggi

Gennaio 26, 2016 Riccardo Raneri

EMA – Metformin and metformin-containing medicines – Review of metformin-containing medicines started

01/02/2016 http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/referrals/Metoformin_and_ metformin-containing_medicines/human_referral_000397.jsp&mid=WC0b01ac05805c516f

Leggi